Mount Sinai Elmhurst Faculty Practice Group in Elmhurst, NY - Surgery

Mount Sinai Elmhurst Faculty Practice Group is a Surgery based in Elmhurst, New York. Mount Sinai Elmhurst Faculty Practice Group is licensed to practice in * (Not Available) (license number ) and their current practice location is 7901 Broadway, Elmhurst, New York. It can be reached at their office (for appointments etc.) via phone at (718) 334-1591.

NPI number for Mount Sinai Elmhurst Faculty Practice Group is 1073867040 and their current mailing address is 7901 Broadway, Elmhurst, New York. Mount Sinai Elmhurst Faculty Practice Group does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1073867040.

Contact Information

	Mount Sinai Elmhurst Faculty Practice Group
	7901 Broadway, Elmhurst, NY 11373-1329
	(718) 334-1591
	(718) 334-4815

Healthcare Provider's Profile

Full Name	Mount Sinai Elmhurst Faculty Practice Group
Type	Facility
Speciality	Surgery
Location	7901 Broadway, Elmhurst, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1073867040
Provider Enumeration Date: 10/30/2012
Last Update Date: 05/10/2016

Medical Identifiers

Medical identifiers for Mount Sinai Elmhurst Faculty Practice Group such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073867040	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	(* (Not Available))	Secondary
207Y00000X	Otolaryngology	(* (Not Available))	Secondary
207YP0228X	Otolaryngology - Pediatric Otolaryngology	(* (Not Available))	Secondary
207YX0007X	Otolaryngology - Plastic Surgery Within The Head & Neck	(* (Not Available))	Secondary
207YX0905X	Otolaryngology - Otolaryngology/facial Plastic Surgery	(* (Not Available))	Secondary
208600000X	Surgery	(* (Not Available))	Primary
2086S0102X	Surgery - Surgical Critical Care	(* (Not Available))	Secondary
2086S0120X	Surgery - Pediatric Surgery	(* (Not Available))	Secondary
2086S0122X	Surgery - Plastic And Reconstructive Surgery	(* (Not Available))	Secondary
2086S0129X	Surgery - Vascular Surgery	(* (Not Available))	Secondary
208G00000X	Thoracic Surgery (cardiothoracic Vascular Surgery)	(* (Not Available))	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mount Sinai Elmhurst Faculty Practice Group is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mount Sinai Elmhurst Faculty Practice Group 7901 Broadway, Elmhurst, NY 11373-1329 Ph: (718) 334-1591	Mount Sinai Elmhurst Faculty Practice Group 7901 Broadway, Elmhurst, NY 11373-1329 Ph: (718) 334-1591

News Archive

Obama uses recess appointment to install Berwick as head of Medicare, Medicaid

President Barack Obama Wednesday will use a recess appointment to install Harvard Professor Donald Berwick to run the Centers for Medicare and Medicaid Services, the White House announced Tuesday.

dGEMRIC index as a predictor of cartilage mechanical stiffness

Can non-destructive MRI provide a measurement of cartilage function? The delayed Gadolinium Enhanced MRI of Cartilage (dGEMRIC) index is highly correlated to mechanical stiffness, and, although not as good as a direct mechanical measurement, the index can be used as a predictive measure of stiffness.

GBS serotype III more commonly associated with urinary tract infections

Research suggests pathogenic strains of Group B Streptococcus (GBS) are an under-recognised cause of urinary tract infections.

New way to exploit expression of BRAF by papillary carcinomas for therapeutic purposes

Papillary carcinoma is the most common form of thyroid cancer. Approximately one quarter of these carcinomas have mutations in the BRAF gene. The prevalence of such mutations is even greater in high-grade carcinomas, particularly those that are refractory to standard treatment, which is radioactive iodine.

Mount Sinai Elmhurst Faculty Practice Group - in Elmhurst, NY